In contrast, osteoclast activation by breast tumor cells is implicated in bone ECM degradation and the release of different growth factors, such as TGF-β, which is implicated in tumor cell growth and metastasis development (Figure 1) [34,35]. Here, TGFB1 is linked to neoplasm.